Pharmacists in West Delray Beach, FL Accepting Medicare
4 Pharmacists found. Showing 1 - 4
 Gicardine Dort Rene Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 13950 S Jog Rd, West Delray Beach, FL 33446 Phone: 561-865-1527 |
 Mr. Warren Edward Gorodess Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 13950 Jog Rd, West Delray Beach, FL 33446 Phone: 561-865-1527 Fax: 561-865-2539 |
Alfred Capria Jr., RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 13950 S Jog Rd, West Delray Beach, FL 33446 Phone: 561-865-1527 |
Antonino Kong, PHARM D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 13950 Jog Rd, West Delray Beach, FL 33446 Phone: 561-865-1527 |
News Archive
Toronto researchers design simple chip for faster, easier detection of antibiotic-resistant bacteria
We live in fear of 'superbugs': infectious bacteria that don't respond to treatment by antibiotics, and can turn a routine hospital stay into a nightmare. A 2015 Health Canada report estimates that superbugs have already cost Canadians $1 billion, and are a "serious and growing issue." Each year two million people in the U.S. contract antibiotic-resistant infections, and at least 23,000 people die as a direct result.
Immune enters into exclusive license with Atlante Biotech for new format of bispecific antibodies
Immune Pharmaceuticals Inc. a clinical-stage company developing novel therapies for the treatment of immuno-inflammatory diseases and cancer, today announced it has entered into an exclusive license with Atlante Biotech SAS, to the patents and know-how for a new format of bispecific antibodies.
High systolic blood pressure in young adults linked to increased risk of cardiovascular problems
Otherwise healthy young people with high systolic blood pressure over 140 are at greater risk for future artery stiffening linked to an increased risk of stroke as well as possible damage to the kidneys and brain, new research shows.
Repros Therapeutics signs settlement agreement with major creditors
Repros Therapeutics today announced that the Company has entered into a settlement agreement with its major creditors for the large majority of the debt incurred associated with the recently suspended Proellex® clinical program.
› Verified 5 days ago